{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T04:29:52Z","timestamp":1794284992346,"version":"4.9.0"},"reference-count":77,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>The majority of patients with systemic sclerosis (SSc) will experience involvement of their gastrointestinal over the course of their disease. Despite the high prevalence of gastrointestinal involvement in SSc, the strategies pertaining to the assessment and treatment for this clinical dimension of SSc have historically been limited. However, the present review highlights recent research contributions that enhance our understanding of SSc-GI patient subsets and provides updates on pathogenic mechanisms of disease, assessment and symptom-directed management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>In the past few years, several studies have identified risk factors for more severe gastrointestinal disease in SSc and have provided insight to optimize diagnosis and management of SSc-GI symptoms. This article also provides a review of currently available investigations and therapies for individual SSc-GI disease manifestations and reflects on actively evolving areas of research, including our understanding the role of the gut microbiome in SSc.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Here, we provide important updates pertaining to the risk stratification, assessment, diagnosis and management of SSc patients with gastrointestinal symptoms. These findings provide opportunities to enhance patient care and highlight exciting opportunities for future research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/bor.0000000000000899","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T11:00:34Z","timestamp":1661166034000},"page":"328-336","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":67,"title":["Gastrointestinal involvement in systemic sclerosis: pathogenesis, assessment and treatment"],"prefix":"10.1097","volume":"34","author":[{"given":"Elizabeth R.","family":"Volkmann","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsanna","family":"McMahan","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,8,19]]},"reference":[{"key":"R1-20250526","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.rdc.2015.04.007","article-title":"Systemic sclerosis: gastrointestinal disease and its management","volume":"41","author":"Gyger","year":"2015","journal-title":"Rheum Dis Clin North Am"},{"key":"R2-20250526","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/RHU.0000000000000626","article-title":"Gastrointestinal involvement in systemic sclerosis: an update","volume":"24","author":"Miller","year":"2018","journal-title":"J Clin Rheumatol"},{"key":"R3-20250526","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s40674-014-0005-0","article-title":"Management of gastrointestinal involvement in scleroderma","volume":"1","author":"Nagaraja","year":"2015","journal-title":"Curr Treatm Opt Rheumatol"},{"key":"R4-20250526","first-page":"51","article-title":"Correlates of depression, including overall and gastrointestinal functional status, among patients with systemic sclerosis","volume":"32","author":"Nietert","year":"2005","journal-title":"J Rheumatol"},{"key":"R5-20250526","doi-asserted-by":"crossref","first-page":"992","DOI":"10.3899\/jrheum.110826","article-title":"Effect of gastrointestinal manifestations on quality of life in 87 consecutive patients with systemic sclerosis","volume":"39","author":"Omair","year":"2012","journal-title":"J Rheumatol"},{"key":"R6-20250526","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.semarthrit.2004.08.009","article-title":"Severe gastrointestinal involvement in systemic sclerosis: report of five cases and review of the literature","volume":"34","author":"Jaovisidha","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"R7-20250526","doi-asserted-by":"crossref","first-page":"142","DOI":"10.55563\/clinexprheumatol\/7683pg","article-title":"Immunosuppression does not prevent severe gastrointestinal tract involvement in systemic sclerosis","volume":"39 Suppl 131","author":"Richard","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"R8-20250526","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA Extension for Scoping Reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"R9-20250526","article-title":"Slow colonic transit in systemic sclerosis: an objective assessment of risk factors and clinical phenotype","author":"Cheah","year":"2021","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R10-20250526","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keac074","article-title":"Gastroparesis in systemic sclerosis: a detailed analysis using whole-gut scintigraphy","author":"Adler","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"R11-20250526","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/acr.24488","article-title":"The relationship between gastrointestinal transit, Medsger GI severity, and UCLA GIT 2.0 symptoms in patients with systemic sclerosis","volume":"74","author":"McMahan","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R12-20250526","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/art.1780370902","article-title":"Gastrointestinal motility disorders in scleroderma","volume":"37","author":"Sjogren","year":"1994","journal-title":"Arthritis Rheum"},{"key":"R13-20250526","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1136\/gut.2005.086074","article-title":"A case-control study of the pathology of oesophageal disease in systemic sclerosis (scleroderma)","volume":"55","author":"Roberts","year":"2006","journal-title":"Gut"},{"key":"R14-20250526","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/0002-9343(69)90044-8","article-title":"Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls","volume":"46","author":"D\u2019Angelo","year":"1969","journal-title":"Am J Med"},{"key":"R15-20250526","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1172\/JCI117395","article-title":"Antimyenteric neuronal antibodies in scleroderma","volume":"94","author":"Howe","year":"1994","journal-title":"J Clin Invest"},{"key":"R16-20250526","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/ard.2008.096545","article-title":"Muscarinic-3 acetylcholine receptor autoantibody in patients with systemic sclerosis: contribution to severe gastrointestinal tract dysmotility","volume":"68","author":"Kawaguchi","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R17-20250526","doi-asserted-by":"crossref","first-page":"G1052","DOI":"10.1152\/ajpgi.00034.2016","article-title":"Role of muscarinic-3 receptor antibody in systemic sclerosis: correlation with disease duration and effects of IVIG","volume":"310","author":"Kumar","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R18-20250526","doi-asserted-by":"crossref","first-page":"G1206","DOI":"10.1152\/ajpgi.00286.2009","article-title":"Immunoglobulins from scleroderma patients inhibit the muscarinic receptor activation in internal anal sphincter smooth muscle cells","volume":"297","author":"Singh","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R19-20250526","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1053\/j.gastro.2012.07.109","article-title":"Effects of scleroderma antibodies and pooled human immunoglobulin on anal sphincter and colonic smooth muscle function","volume":"143","author":"Singh","year":"2012","journal-title":"Gastroenterology"},{"key":"R20-20250526","first-page":"2227","article-title":"Antivinculin antibodies in scleroderma (SSc): a potential link between autoimmunity and gastrointestinal system involvement in two SSc cohorts","volume":"40","author":"Suliman","year":"2020","journal-title":"Clin Rheumatol"},{"key":"R21-20250526","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/acr.23763","article-title":"Anti-RNPC-3\u200a(U11\/U12) antibodies in systemic sclerosis in patients with moderate-to-severe gastrointestinal dysmotility","volume":"71","author":"McMahan","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R22-20250526","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21041332","article-title":"Ganglionic acetylcholine receptor antibodies and autonomic dysfunction in autoimmune rheumatic diseases","volume":"21","author":"Imamura","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R23-20250526","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000212370","article-title":"Autoimmune autonomic ganglionopathy","volume":"26","author":"Winston","year":"2009","journal-title":"Front Neurol Neurosci"},{"key":"R24-20250526","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.3899\/jrheum.170868","article-title":"Symptoms of autonomic dysfunction in systemic sclerosis assessed by the COMPASS-31 questionnaire","volume":"45","author":"Adler","year":"2018","journal-title":"J Rheumatol"},{"key":"R25-20250526","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/978-1-4939-0897-4_3","article-title":"The enteric nervous system and gastrointestinal innervation: integrated local and central control","volume":"817","author":"Furness","year":"2014","journal-title":"Adv Exp Med Biol"},{"key":"R26-20250526","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.semarthrit.2013.05.002","article-title":"Neurologic involvement in scleroderma: a systematic review","volume":"43","author":"Amaral","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"R27-20250526","first-page":"1203","article-title":"Autonomic nervous system and smooth muscle cell involvement in systemic sclerosis: ultrastructural study of 3 cases","volume":"27","author":"Malandrini","year":"2000","journal-title":"J Rheumatol"},{"key":"R28-20250526","first-page":"402583","article-title":"Anorectal motility and sensation abnormalities and its correlation with anorectal symptoms in patients with systemic sclerosis: a preliminary study","author":"Sallam","year":"2011","journal-title":"ISRN Gastroenterol"},{"key":"R29-20250526","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1023\/A:1010779729184","article-title":"Proximal stomach function in systemic sclerosis: relationship with autonomic nerve function","volume":"46","author":"Iovino","year":"2001","journal-title":"Dig Dis Sci"},{"key":"R30-20250526","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-230X-8-7","article-title":"Gastrointestinal symptoms and motility disorders in patients with systemic scleroderma","volume":"8","author":"Di Ciaula","year":"2008","journal-title":"BMC Gastroenterol"},{"key":"R31-20250526","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.1442-2050.1999.00005.x","article-title":"Esophageal motor disturbances in progressive systemic sclerosis","volume":"12","author":"Henry","year":"1999","journal-title":"Dis Esophagus"},{"key":"R32-20250526","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1007\/s10620-018-5175-4","article-title":"A positive correlation between gastric and esophageal dysmotility suggests common causality","volume":"63","author":"Zikos","year":"2018","journal-title":"Dig Dis Sci"},{"key":"R33-20250526","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00296-010-1595-y","article-title":"Early endoscopy in systemic sclerosis without gastrointestinal symptoms","volume":"32","author":"Thonhofer","year":"2012","journal-title":"Rheumatol Int"},{"key":"R34-20250526","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1442-2050.2010.01150.x","article-title":"Esophageal dysmotility associated with systemic sclerosis: a high-resolution manometry study","volume":"24","author":"Roman","year":"2011","journal-title":"Dis Esophagus"},{"key":"R35-20250526","first-page":"247","article-title":"Manifestations of gastro-pharyngo-laryngeal reflux disease","volume":"26","author":"Mosca","year":"2006","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"R36-20250526","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.clineuro.2007.01.006","article-title":"Myasthenia gravis and scleroderma: two cases and a review of the literature","volume":"109","author":"Zivkovi\u0107","year":"2007","journal-title":"Clin Neurol Neurosurg"},{"key":"R37-20250526","first-page":"1409","article-title":"Myasthenia gravis and scleroderma","volume":"20","author":"Bhalla","year":"1993","journal-title":"J Rheumatol"},{"key":"R38-20250526","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.3748\/wjg.v27.i31.5201","article-title":"Dysphagia, reflux and related sequelae due to altered physiology in scleroderma","volume":"27","author":"Kadakuntla","year":"2021","journal-title":"World J Gastroenterol"},{"key":"R39-20250526","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13075-016-1094-y","article-title":"The 5-HT1A receptor agonist buspirone improves esophageal motor function and symptoms in systemic sclerosis: a 4-week, open-label trial","volume":"18","author":"Karamanolis","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"R40-20250526","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.18103\/mra.v8i10.2252","article-title":"Clinical assessment of gastrointestinal involvement in patients with systemic sclerosis","volume":"8","author":"Kaniecki","year":"2020","journal-title":"Med Res Arch"},{"key":"R41-20250526","doi-asserted-by":"crossref","first-page":"101666","DOI":"10.1016\/j.berh.2021.101666","article-title":"A practical approach to the evaluation and management of gastrointestinal symptoms in patients with systemic sclerosis","volume":"35","author":"Kaniecki","year":"2021","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R42-20250526","doi-asserted-by":"crossref","first-page":"517","DOI":"10.14309\/ajg.0000000000001109","article-title":"Prevalence of Barrett's esophagus in female patients with scleroderma","volume":"116","author":"Snyder","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"R43-20250526","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.cgh.2016.03.039","article-title":"Loss of peristaltic reserve, determined by multiple rapid swallows, is the most frequent esophageal motility abnormality in patients with systemic sclerosis","volume":"14","author":"Carlson","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R44-20250526","doi-asserted-by":"crossref","first-page":"718-e741","DOI":"10.1111\/j.1365-2982.2009.01273.x","article-title":"Multiple rapid swallowing: a complementary test during standard oesophageal manometry","volume":"21","author":"Fornari","year":"2009","journal-title":"Neurogastroenterol Motil"},{"key":"R45-20250526","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/23971983211021747","article-title":"Use of vonoprazan, a novel potassium-competitive acid blocker, for the treatment of proton pump inhibitor-refractory reflux esophagitis in patients with systemic sclerosis","volume":"7","author":"Shirai","year":"2022","journal-title":"J Scleroderma Relat Disord"},{"key":"R46-20250526","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3892\/br.2020.1401","article-title":"Use of vonoprazan for management of systemic sclerosis-related gastroesophageal reflux disease","volume":"14","author":"Tabuchi","year":"2021","journal-title":"Biomed Rep"},{"key":"R47-20250526","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/apt.13461","article-title":"Randomised clinical trial: vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis","volume":"43","author":"Ashida","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"R48-20250526","doi-asserted-by":"crossref","first-page":"477","DOI":"10.5056\/jnm19148","article-title":"Esophageal involvement and determinants of perception of esophageal symptoms among South Koreans with systemic sclerosis","volume":"26","author":"Lee","year":"2020","journal-title":"J Neurogastroenterol Motil"},{"key":"R49-20250526","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/dote\/dox067","article-title":"Spectrum of esophageal dysmotility in systemic sclerosis on high-resolution esophageal manometry as defined by Chicago classification","volume":"30","author":"Aggarwal","year":"2017","journal-title":"Dis Esophagus"},{"key":"R50-20250526","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.3748\/wjg.v20.i9.2412","article-title":"Addition of prokinetics to PPI therapy in gastroesophageal reflux disease: a meta-analysis","volume":"20","author":"Ren","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R51-20250526","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s00423-021-02118-8","article-title":"Surgical treatment of recalcitrant gastroesophageal reflux disease in patients with systemic sclerosis: a systematic review","volume":"406","author":"Aiolfi","year":"2021","journal-title":"Langenbecks Arch Surg"},{"key":"R52-20250526","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11894-019-0699-0","article-title":"Colonic and anorectal manifestations of systemic sclerosis","volume":"21","author":"Sattar","year":"2019","journal-title":"Curr Gastroenterol Rep"},{"key":"R53-20250526","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.14309\/ajg.0000000000000397","article-title":"Colonic manifestations and complications are relatively under-reported in systemic sclerosis: a systematic review","volume":"114","author":"Brandler","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"R54-20250526","first-page":"S-214","article-title":"Consensus best practice pathway of the UK scleroderma study group: gastrointestinal manifestations of systemic sclerosis","volume":"32","author":"Hansi","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"R55-20250526","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/MOG.0000000000000040","article-title":"Small intestinal bacterial overgrowth: what it is and what it is not","volume":"30","author":"Quigley","year":"2014","journal-title":"Curr Opin Gastroenterol"},{"key":"R56-20250526","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/rheumatology\/kep226","article-title":"Small intestinal bacterial overgrowth in systemic sclerosis","volume":"48","author":"Marie","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"R57-20250526","doi-asserted-by":"crossref","first-page":"101","DOI":"10.5114\/ada.2020.101468","article-title":"Gut microbiome in systemic sclerosis: a potential therapeutic target","volume":"39","author":"Polkowska-Pruszy\u0144ska","year":"2022","journal-title":"Postepy Dermatol Alergol"},{"key":"R58-20250526","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/nmo.12516","article-title":"Small intestinal bacterial overgrowth: duodenal aspiration vs glucose breath test","volume":"27","author":"Erdogan","year":"2015","journal-title":"Neurogastroenterol Motil"},{"key":"R59-20250526","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1007\/s10620-018-4977-8","article-title":"Intestinal involvement in systemic sclerosis: a clinical review","volume":"63","author":"Sakkas","year":"2018","journal-title":"Dig Dis Sci"},{"key":"R60-20250526","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/acr2.11387","article-title":"Disease features and gastrointestinal microbial composition in patients with systemic sclerosis from two independent cohorts","volume":"4","author":"Andr\u00e9asson","year":"2022","journal-title":"ACR Open Rheumatol"},{"key":"R61-20250526","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcmgh.2018.04.003","article-title":"The brain-gut-microbiome axis","volume":"6","author":"Martin","year":"2018","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"R62-20250526","first-page":"353245","article-title":"Pneumatosis cystoides intestinalis: a rare benign cause of pneumoperitoneum","volume":"2013","author":"Devgun","year":"2013","journal-title":"Case Rep Radiol"},{"key":"R63-20250526","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1464-410X.1986.tb05911.x","article-title":"Biochemical monitoring of carcinoma of prostate treated with an LH-RH analogue (Zoladex)","volume":"58","author":"Siddall","year":"1986","journal-title":"Br J Urol"},{"key":"R64-20250526","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/gut.21.4.293","article-title":"Small intestinal structure and passive permeability in systemic sclerosis","volume":"21","author":"Cobden","year":"1980","journal-title":"Gut"},{"key":"R65-20250526","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0049-0172(90)90049-L","article-title":"Pneumatosis cystoides intestinalis in systemic sclerosis and other diseases","volume":"19","author":"Sequeira","year":"1990","journal-title":"Semin Arthritis Rheum"},{"key":"R66-20250526","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1148\/76.5.733","article-title":"Pneumatosis intestinalis: a new concept","volume":"76","author":"Keyting","year":"1961","journal-title":"Radiology"},{"key":"R67-20250526","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1001\/archsurg.1974.01360010067017","article-title":"The bacterial etiology of pneumatosis cystoides intestinalis","volume":"109","author":"Yale","year":"1974","journal-title":"Arch Surg"},{"key":"R68-20250526","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.amjsurg.2008.01.011","article-title":"Management and outcome of pneumatosis intestinalis","volume":"195","author":"Morris","year":"2008","journal-title":"Am J Surg"},{"key":"R69-20250526","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s100670170038","article-title":"Colonic transit disorders in systemic sclerosis","volume":"20","author":"Wang","year":"2001","journal-title":"Clin Rheumatol"},{"key":"R70-20250526","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.semarthrit.2019.05.005","article-title":"Evaluation of risk factors for pseudo-obstruction in systemic sclerosis","volume":"49","author":"Dein","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"R71-20250526","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/acr.24488","article-title":"Relationship between gastrointestinal transit, Medsger gastrointestinal severity, and University of California-Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract 2.0 symptoms in patients with systemic sclerosis","volume":"74","author":"McMahan","year":"2022","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R72-20250526","first-page":"227","article-title":"Intestinal obstruction and pseudo-obstruction in patients with systemic sclerosis","volume":"43","author":"Zapatier","year":"2013","journal-title":"Acta Gastroenterol Latinoam"},{"key":"R73-20250526","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/rheumatology\/kev393","article-title":"Intestinal pseudo-obstruction in patients with systemic sclerosis: an analysis of the Nationwide Inpatient Sample","volume":"55","author":"Valenzuela","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"R74-20250526","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/003655299750026434","article-title":"Bowel problems in patients with systemic sclerosis","volume":"34","author":"Trezza","year":"1999","journal-title":"Scand J Gastroenterol"},{"key":"R75-20250526","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1177\/2050640616688129","article-title":"Prevalence of fecal incontinence in a cohort of systemic sclerosis patients within a regional referral network","volume":"5","author":"Garros","year":"2017","journal-title":"United European Gastroenterol J"},{"key":"R76-20250526","doi-asserted-by":"crossref","first-page":"100","DOI":"10.5114\/reum.2017.67606","article-title":"Stubborn rectal prolapse in systemic sclerosis","volume":"55","author":"Petersen","year":"2017","journal-title":"Reumatologia"},{"key":"R77-20250526","first-page":"31348211047487","article-title":"High failure rate following restorative surgery for rectal prolapse in systemic sclerosis patients","author":"Kahana","year":"2021","journal-title":"Am Surg"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000899","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T17:19:21Z","timestamp":1748279961000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,19]]},"references-count":77,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000899","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,19]]}}}